A<unk>  is a coronary artery stent that combines the technology of an antibody-coated stent and a drug-eluting stent. Currently, second-generation drug-eluting stents require long-term use of<unk> -antiplatelet<unk> , which increases the risk of major bleeding occurrences in patients. Compared to drug-eluting stents,<unk> s have improved vessel regeneration and cell proliferation capabilities. As a result,<unk> s were developed to reduce the long-term need for<unk> -antiplatelet<unk> . The COMBO stent is the first and only<unk>  that addresses the challenges of vessel healing in drug-eluting stents. This stent is an anti-CD34 antibody-coated and sirolimus-eluting bioresorbable stent. The COMBO stent combines the Genous stent's endothelial cell capture technology with an antiproliferative, biodegradable sirolimus drug elution. The COMBO stent has received CE Mark approval.
Dual therapy stent
Cypher stent
Bare-metal stent
Bypass surgery
Distal Revascularization and Interval Ligation
Endoscopic vessel harvesting
Embolization
Mustard procedure